The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapy
Open accessAbstract
The most common metabolic hallmark of malignant tumors, i.e., the “Warburg effect” is their propensity to metabolize glucose to lactic acid at a high rate even in the presence of oxygen. The pivotal player in this frequent cancer phenotype is mitochondrial-bound hexokinase [Bustamante E, Pedersen PL. High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc Natl Acad Sci USA 1977;74(9):3735−9; Bustamante E, Morris HP, Pedersen PL. Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem 1981;256(16):8699−704]. Now, in clinics worldwide this prominent phenotype forms the basis of one of the most common detection systems for cancer, i.e., positron emission tomography (PET). Significantly, HK-2 is the major bound hexokinase isoform expressed in cancers that exhibit a “Warburg effect”. This includes most cancers that metastasize and kill their human host. By stationing itself on the outer mitochondrial membrane, HK-2 also helps immortalize cancer cells, escapes product inhibition and gains preferential access to newly synthesized ATP for phosphorylating glucose. The latter event traps this essential nutrient inside the tumor cells as glucose-6-P, some of which is funneled off to serve as carbon precursors to help promote the production of new cancer cells while much is converted to lactic acid that exits the cells. The resultant acidity likely wards off an immune response while preparing surrounding tissues for invasion. With the re-emergence and acceptance of both the “Warburg effect” as a prominent phenotype of most clinical cancers, and “metabolic targeting” as a rational therapeutic strategy, a number of laboratories are focusing on metabolite entry or exit steps. One remarkable success story [Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, et al. Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun 2004;324(1):269−75] is the use of the small molecule 3-bromopyruvate (3-BP) that selectively enters and destroys the cells of large tumors in animals by targeting both HK-2 and the mitochondrial ATP synthasome. This leads to very rapid ATP depletion and tumor destruction without harm to the animals. This review focuses on the multiple roles played by HK-2 in cancer and its potential as a metabolic target for complete cancer destruction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function
Wilson, J. E. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00241 · Cited by 1,085
Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death
Baines, C. P., Kaiser, R. A., Sheiko, T., Craigen, W. J., & Molkentin, J. D. (2007) · Nature Cell Biology · doi:10.1038/ncb1575 · Cited by 971
Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R. B., & Hay, N. (2001) · Genes & Development · doi:10.1101/gad.889901 · Cited by 961
Mathupala, S. P., Ko, Y. H., & Pedersen, P. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209603 · Cited by 765
Self-citationDi Chiro, G., DeLaPaz, R. L., Brooks, R. A., Sokoloff, L., Kornblith, P. L., Smith, B. H., Patronas, N. J., Kufta, C. V., Kessler, R. M., Johnston, G. S., et al. (1982) · Neurology · doi:10.1212/wnl.32.12.1323 · Cited by 752
Tumor Mitochondria and the Bioenergetics of Cancer Cells
Pedersen, P. L. (2015) · Progress in Tumor Research · doi:10.1159/000401202 · Cited by 711
Self-citationDichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
Michelakis, E. D., Webster, L., & Mackey, J. R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604554 · Cited by 656
Majewski, N., Nogueira, V., Bhaskar, P., Coy, P. E., Skeen, J. E., Gottlob, K., Chandel, N. S., Thompson, C. B., Robey, R. B., & Hay, N. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.014 · Cited by 633
Causes and Consequences of Increased Glucose Metabolism of Cancers
Gillies, R. J., Robey, I., & Gatenby, R. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047258 · Cited by 623
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt
Robey, R. B., & Hay, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209595 · Cited by 536
Akt-dependent transformation: there is more to growth than just surviving
Plas, D. R., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1209097 · Cited by 429
Pedersen, P. L. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9094-x · Cited by 425
Self-citationHigh aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase
Bustamante, E., & Pedersen, P. L. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3735 · Cited by 394
Self-citationGlucose Catabolism in Cancer Cells
Mathupala, S. P., Rempel, A., & Pedersen, P. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108181200 · Cited by 373
Self-citationWilson, J. E. (2006) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/bfb0049776 · Cited by 366
Pedersen, P. L., Mathupala, S., Rempel, A., Geschwind, J. F., & Ko, Y. H. (2002) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(02)00248-7 · Cited by 356
Self-citationAdvanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
Ko, Y. H., Smith, B. L., Wang, Y., Pomper, M. G., Rini, D. A., Torbenson, M. S., Hullihen, J., & Pedersen, P. L. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.047 · Cited by 352
Self-citationKo, Y. H., Pedersen, P. L., & Geschwind, J. F. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00667-x · Cited by 347
Self-citationArora, K. K., & Pedersen, P. L. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77853-3 · Cited by 323
Self-citationBustamante, E., Morris, H. P., & Pedersen, P. L. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68900-3 · Cited by 314
Self-citationThe glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
Gatenby, R. A., & Gawlinski, E. T. (2003) · PubMed · Cited by 314
Chiara, F., Castellaro, D., Marin, O., Petronilli, V., Brusilow, W. S., Juhaszova, M., Sollott, S. J., Forte, M., Bernardi, P., & Rasola, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001852 · Cited by 290
Hexokinase II: The Integration of Energy Metabolism and Control of Apoptosis
Pastorino, J., & Hoek, J. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457269 · Cited by 257
Glucose Catabolism in Cancer Cells
Mathupala, S. P., Heese, C., & Pedersen, P. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22776 · Cited by 231
Self-citationGlucose Catabolism in Cancer Cells.
Mathupala, S. P., Rempel, A., & Pedersen, P. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16918 · Cited by 229
Self-citationNakashima, R. A., Mangan, P. S., Colombini, M., & Pedersen, P. L. (1986) · Biochemistry · doi:10.1021/bi00353a010 · Cited by 222
Self-citationRat glucokinase gene: structure and regulation by insulin.
Magnuson, M. A., Andreone, T. L., Printz, R. L., Koch, S., & Granner, D. K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.4838 · Cited by 219
Methyl jasmonate binds to and detaches mitochondria-bound hexokinase
Goldin, N., Arzoine, L., Heyfets, A., Israelson, A., Zaslavsky, Z., Bravman, T., Bronner, V, Notcovich, A., Shoshan-Barmatz, V, & Flescher, E. (2008) · Oncogene · doi:10.1038/onc.2008.108 · Cited by 208
Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase.
Rempel, A., Mathupala, S. P., Griffin, C. A., Hawkins, A. L., & Pedersen, P. L. (1996) · PubMed · Cited by 173
Self-citationGoel, A., Mathupala, S. P., & Pedersen, P. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300608200 · Cited by 155
Self-citationMathupala, S. P., Parajuli, P., & Sloan, A. E. (2004) · Neurosurgery · doi:10.1227/01.neu.0000143034.62913.59 · Cited by 147
Self-citationMitochondriotoxic compounds for cancer therapy
Fantin, V. R., & Leder, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209599 · Cited by 147
Clotrimazole and bifonazole detach hexokinase from mitochondria of melanoma cells
Penso, J., & Beitner, R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01507-0 · Cited by 136
Mitochondrial Hexokinases: Guardians of the Mitochondria
Robey, R. B., & Hay, N. (2005) · Cell Cycle · doi:10.4161/cc.4.5.1678 · Cited by 109
Functional Organization of Mammalian Hexokinase II
Ardehali, H., Yano, Y., Printz, R. L., Koch, S., Whitesell, R. R., May, J. M., & Granner, D. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1849 · Cited by 98
Lactate and malignant tumors: A therapeutic target at the end stage of glycolysis
Mathupala, S. P., Colen, C. B., Parajuli, P., & Sloan, A. E. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-006-9062-x · Cited by 83
Self-citationCao, X., Bloomston, M., Zhang, T., Frankel, W. L., Jia, G., Wang, B., Hall, N. C., Koch, R. M., Cheng, H., Knopp, M. V., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1607 · Cited by 83
Tsai, H. J., & Wilson, J. E. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0186 · Cited by 79
Colen, C. B., Seraji‐Bozorgzad, N., Marples, B., Galloway, M. P., Sloan, A. E., & Mathupala, S. P. (2006) · Neurosurgery · doi:10.1227/01.neu.0000249218.65332.bf · Cited by 76
Self-citationRempel, A., Bannasch, P., & Mayer, D. (1994) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(94)90225-9 · Cited by 72
Mitochondrial hexokinase of rat hepatoma cells in culture: solubilization and kinetic properties
Bustamante, E., & Pedersen, P. L. (1980) · Biochemistry · doi:10.1021/bi00563a006 · Cited by 67
Self-citationAn introduction to the isoenzymes of mammalian hexokinase types I-III
Wilson, J. E. (1997) · Biochemical Society Transactions · doi:10.1042/bst0250103 · Cited by 63
Lee, M. G., & Pedersen, P. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307031200 · Cited by 53
Self-citationTsai, H. J., & Wilson, J. E. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.9850 · Cited by 47
Tsai, H. J., & Wilson, J. E. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1029 · Cited by 43
Evidence that transcription of the hexokinase gene is increased in a rapidly growing rat hepatoma
Johansson, T., Berrez, J.-M., & Nelson, B. D. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)90948-9 · Cited by 26
The Role of Mitochondrial Hexokinase Binding in the Abnormal Energy Metabolism of Tumor Cell Lines
Nakashima, R. A., Scott, L. J., & Pedersen, P. L. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb54423.x · Cited by 19
Self-citation
Cited by
Targeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
Tumor glycolysis as a target for cancer therapy: progress and prospects
Ganapathy-Kanniappan, S., & Geschwind, J.-F. H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-152 · Cited by 1,395
Cancer Cell Metabolism: One Hallmark, Many Faces
Cantor, J. R., & Sabatini, D. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0345 · Cited by 947
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Dang, C. V., Le, A., & Gao, P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0889 · Cited by 946
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner
Kalender, A., Selvaraj, A., Kim, S. Y., Gulati, P., Brûlé, S., Viollet, B., Kemp, B. E., Bardeesy, N., Dennis, P., Schlager, J. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.014 · Cited by 889
Metadata
- Authors
- Mathupala, S. P., Ko, Y. H., & Pedersen, P. L.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 19
- Issue
- 1
- Pages
- 17-24
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2137960344
- Cited by
- 574
- References
- 51
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.